Format

Send to

Choose Destination
Trends Immunol. 2013 Aug;34(8):361-70. doi: 10.1016/j.it.2013.02.007. Epub 2013 Mar 27.

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Author information

1
Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Tumor Immunology Laboratory, Geert Grooteplein 28, 6525 GA, Nijmegen, The Netherlands.

Abstract

Antigen cross-presentation describes the process through which dendritic cells (DCs) acquire exogenous antigens for presentation on MHC class I molecules. The ability to cross-present has been thought of as a feature of specialized DC subsets. Emerging data, however, suggest that the cross-presenting ability of each DC subset is tuned by and dependent on several factors, such as DC location and activation status, and the type of antigen and inflammatory signals. Thus, we argue that capacity of cross-presentation is not an exclusive trait of one or several distinct DC subtypes, but rather a common feature of the DC family in both mice and humans. Understanding DC subset activation and antigen-presentation pathways might yield improved tools and targets to exploit the unique cross-presenting capacity of DCs in immunotherapy.

KEYWORDS:

antigen presentation; cross-presentation; dendritic cell subsets; immunotherapy

PMID:
23540650
PMCID:
PMC4351710
DOI:
10.1016/j.it.2013.02.007
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center